USP3 and renal cell carcinoma: However, the results of ChIP assays indicated that USP3 was not significantly enriched in the anti-ETS1 and anti-SPI1 groups, suggesting that USP3 was not specifically targeted by ETS1 and SPI1 in RCC cells (Fig. S1D-E).